| Dr William H Hall, DMD, PC | |
|
711 Glover Ave, Enterprise, AL 36330-2015 | |
| (334) 393-0338 | |
| (334) 393-7778 |
| Full Name | Dr William H Hall |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 711 Glover Ave, Enterprise, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538133137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 4788 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William H Hall, DMD, PC 711 Glover Ave, Enterprise, AL 36330-2015 Ph: (334) 393-0338 | Dr William H Hall, DMD, PC 711 Glover Ave, Enterprise, AL 36330-2015 Ph: (334) 393-0338 |
News Archive
A new type of drug originally developed for lung cancer can reduce the size of breast cancer tumours when taken in combination with other drugs.
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and MitoPower LLC were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism.
Only about half of infants born to HIV-infected mothers in some African countries receive a minimum preventive dose of the drug nevirapine to help reduce the risk of mother-to-child HIV transmission, according to a study in the July 21 issue of JAMA, a theme issue on HIV/AIDS.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
A team of Italian investigators has discovered a new variant of an emerging antibiotic resistance mechanism. The new variant, dubbed mcr-1.2, confers resistance to colistin, a last-resort antibiotic against multidrug-resistant Gram-negative pathogens.
› Verified 1 days ago
Dr. Harutun Arthur Missirlian, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2 E Pointe Ct, Enterprise, AL 36330 Phone: 334-347-3061 Fax: 334-347-1101 | |
Dr. William Baxter Collier Jr., DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 442 Glover Ave, Enterprise, AL 36330 Phone: 334-347-5026 Fax: 334-347-0117 | |
Dr. Solange Perez Johnson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2 E Pointe Ct, Enterprise, AL 36330 Phone: 334-347-3061 | |
Dr. Brad Lomax Marsh, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 412 Glover Ave, Enterprise, AL 36330 Phone: 334-347-6702 | |
Dr. William Nicholas Turner, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 736 E Lee St, Enterprise, AL 36330 Phone: 334-347-0096 | |
Dr. Kanecia Tolbert, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 623 Boll Weevil Cir Ste 1, Enterprise, AL 36330 Phone: 334-352-3777 | |
Dr. Andrew J Mills, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 204 N Edwards St, Enterprise, AL 36330 Phone: 334-347-8538 Fax: 334-393-2316 |